<DOC>
	<DOCNO>NCT01697111</DOCNO>
	<brief_summary>This multi-center , randomize , double-blinded , placebo-controlled , parallel-group study ( 24-week treatment-comparison phase ) open-label reference arm active comparator ( dienogest ) follow 28-week long-term treatment phase . The primary objective study confirm superiority BAY86-5300 administer extend flexible regimen treatment endometriosis-associated pelvic pain comparison placebo Japanese endometriosis patient within 24 week . The secondary objective investigate long-term safety BAY86-5300 patient treat extended flexible regimen one year , bleed pattern BAY86-5300 administer extend flexible regimen compare dienogest .</brief_summary>
	<brief_title>Comparative Study BAY86-5300 With Extended Flexible Regimen Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>Patients diagnose endometriosis laparotomy laparoscopy , identification chocolate cyst endometriosis , patient clinical diagnosis endometriosis , fulfill condition pelvic tenderness induration Culdesac uterine immobility Patient pelvic pain judge high Visual Analogue Scale ( VAS ) value 40 mm high determine 2 menstrual cycle randomization ( baseline observation phase ) Patients normal menstrual cycle ( 25 38 day ) late two menses randomization ( baseline observation phase ) Patients wish become pregnant course study Patients organic disease surgical treatment prioritize investigator Patients hormonal therapy , include combine oral contraceptive ( COCs ) progestins , fail treatment symptomatic endometriosis ( moderate , severe pain ) Patients YAZ Combination Tablet contraindicate ( accord Japanese Labeling ) Patients dienogest contraindicate ( accord Japanese labeling Dinagest Tab 1mg )</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>YAZ</keyword>
	<keyword>Flexible regimen</keyword>
	<keyword>Drospirenone</keyword>
	<keyword>Ethinylestradiol Betadex</keyword>
	<keyword>Endometriosis</keyword>
	<keyword>Dienogest</keyword>
	<keyword>Japanese Patients</keyword>
</DOC>